ASH Clinical News September 2016 | Page 10

VOLUME 02 | NUMBER 09 | SEPTEMBER 2016 Around the Network IN THIS ISSUE interview Revisiting Certification Marc S. Zumberg, MD, and Michael E. Williams, MD, ScM, discuss recent changes to the American Board of Internal Medicine’s Maintenance of Certification program and how they will affect practicing hematologists. 58 clinical news ASSOCIATE EDITORS Extends Survival for Acute Promyelocytic Leukemia 43 S  ickle Cell Trait Not Associated With Increased Risk of Death in African-American U.S. Army Soldiers The transition and transfer of patients with hematologic conditions from pediatric to adult care often comes at a crucial time. ASH Clinical News spoke with several physicians about transitioning young adult patients to the adult system and what can be done to make this transition smooth and successful for the patient, their caregivers, and their health-care team. 55 51 A  Report from the ASH Workshop on Genome Editing: Harnessing the Power of Gene Editing Correction: On page 10 of our August issue, we neglected to include the photo credit for the image on the cover of Blood Advances. The image should have been credited to Steve Gschmeissner/Getty Images. We apologize for the error. ASHCLINICALNEWS.ORG @ASHCLINICALNEWS On September 16-17, ASH Clinical News will be in Chicago to report from the 2016 ASH Meeting on Hematologic Malignancies. Look for our e-newsletters that will include updates from the meeting and interviews with presenters at ashclinicalnews.org/ category/on-location/ash-meetingon-hematologic-malignancies. Have a comment about something you see in the magazine? Let us know your thoughts in 140 characters or less and tweet us at @ASHClinicalNews. Have you checked out our new Online Exclusives section for up-to-date news from the hematology/oncology community? Visit ashclinicalnews. org/category/online-exclusive for daily updates. EDITOR-IN-CHIEF Mikkael Sekeres, MD, MS Vice-Chair for Clinical Research Director, Leukemia Program Cleveland Clinic, Taussig Cancer Institute Cleveland, OH 35 Arsenic Trioxid e Plus All-Trans Retinoic Acid Coming of Age AMERICAN SOCIETY OF HEMATOLOGY (ASH) HEADQUARTERS 2021 L Street NW, Suite 900 Washington, DC 20036 www.hematology.org Tel: [phone] And don’t forget to sign up to receive our e-newsletters to have the latest updates from ASH Clinical News delivered to your inbox: ashclinicalnews.org/ enewsletter-sign-up. Beth Faiman, CNP, PhD Cleveland Clinic Cleveland, OH Alice Ma, MD University of North Carolina School of Medicine Chapel Hill, NC David Steensma, MD Dana-Farber Cancer Institute Boston, MA Keith Stewart, MBChB, MBA Mayo Clinic Scottsdale, AZ PUBLISHER American Medical Communications (AMC) EDITORIAL MANAGING EDITORS Ariel Jones-DeMaio, AMC Karen Learner, ASH ASSOCIATE MANAGING EDITOR Kerri Fitzgerald, AMC ART DIRECTOR Ari Mihos ASSISTANT ART DIRECTORS Charlene DePrizio John Salesi DIGITAL PROJECTS MANAGER Chris Gedikli ADVERTISING ACCOUNT MANAGER Nick Luciano [email protected] Gene Conselyea [email protected] Recruitment advertising orders can be sent to: DIRECTOR, RECRUITMENT CLASSIFIEDS Lauren Morgan [email protected] Subscription inquiries should be sent to: [email protected] All correspondence for the American Society of Hematology should be sent to: American Society of Hematology, 2021 L Street NW, Suite 900, Washington DC 20036. Neither the American Society of Hematology nor the publisher is responsible for statements made by any editor or contributor. Statements, editorials, or opinions expressed in ASH Clinical News magazine do not necessarily represent official policy of the American Society of Hematology unless so stated. No responsibility is assumed by the American Society of Hematology or the Publisher for any injury or damage to persons or property as a matter of product liability, negligence or otherwise or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Although all advertising material published in ASH Clinical News magazine is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement by the American Society of Hematology or the Publisher of the quality or value of such product or of the claim made of it by its manufacturer. About the American Society of Hematology The American Society of Hematology (ASH) is the world’s largest professional society concerned with the causes and treatments of blood disorders. The mission of the Society is to further the understanding, diagnosis, treatment, and prevention of disorders affecting the blood, bone marrow, and the immunologic, hemostatic and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology. ASH Clinical News (ISSN 2375-8120) is published once per month by American Medical Communications, 630 Madison Avenue, 2nd Floor, Manalapan, NJ 07726. Periodicals postage is pending/paid at Manalapan, NJ and additional mailing offices. POSTMASTER: Send address changes to American Medical Communications, 630 Madison Avenue, 2nd Floor, Manalapan, NJ 07726. ©Copyright, 2016. 8 ASH Clinical News Visit us at ashclinicalnews.org Follow us on Twitter @ASHClinicalNews ©2016 by the American Society of Hematology. All materials contained in this newsletter are protected by copyright laws and may not be used, reproduced, or otherwise exploited in any manner without the express prior written permission of ASH Clinical News. Any third-party materials communicated to ASH Clinical News become its copyrighted property and may be used, reproduced, or otherwise exploited by ASH Clinical News. September 2016